Pharma & Health News Top Stories Today – HealthWHO says antimicrobial resistance efforts improve globally but remain off track for 2030 goals 16/11/2026Of 183 countries surveyed, 173 reported having a national action plan to tackle AMR, up from 79 in 2017. Only 42, however, said their plans were financed and implemented.GLP-1 Therapies in India Need Tailored Treatment Protocols as Weight Loss Alone Cannot Define Success: Dr Shashank Joshi 16/11/2026GLP-1 therapies are changing the treatment of diabetes and obesity, but their growing use also raises questions about nutritional deficiencies, muscle loss, bone health and long-term adherence. Dr Shashank R. Joshi, Department of Diabetology and Endocrinology, Lilavati Hospital and Research Centre, argues that Indian patients need a more comprehensive approach to treatment, combining nutritional assessment, […]New study finds fine particulate air pollution as a key factor leading to upsurge in type 2 diabetes 16/11/2026Synthesising data spanning more than 200 million cumulative participant observations worldwide, the study establishes that air pollution is no longer solely a cardiopulmonary concern, but a potent, systemic metabolic disruptor demanding urgent integration into cardiometabolic prevention frameworks with profound implications for high-exposure regions like South Asia.In a first, AIIMS Delhi performs surgery to repair baby’s spine before birth 15/11/2026AIIMS Delhi has successfully performed surgery on an unborn baby to repair a severe birth defect. The procedure aimed to treat myelomeningocele, the most severe form of spina bifida. It was conducted on a baby at 25 weeks of pregnancy, offering hope for reduced neurological damage. Both the mother and foetus are now stable and […]Blood-brain barrier discovery could lead to new Alzheimer's disease approach 14/11/2026Working in mice, the researchers used protein-labeling chemistry to tag 861 mouse blood proteins that were re-injected into the bloodstream. Brain tissue analyses showed 92 had been allowed to cross the blood-brain barrier.Manipal posts ₹ 3,399 cr in Q2 FY27, net profit rises 21.6% 13/11/2026Consolidated ARPOB stood at Rs 70,600 per day; excluding Sahyadri, ARPOB was Rs 76,600 per day, up 8.5 per cent. Inpatient volumes grew 35.0 per cent to approximately 169,000 and outpatient volumes rose 27.2 per cent to approximately 1.74 million.Six in 10 Indians consider online health information as reliable as advice from doctors: Study 13/11/2026The report titled ‘The Consumerization of Health Care: How Patients Are Reshaping the Industry’ surveyed 976 consumers in India to study the shift in how patients approach health care, with growing expectations for choice, transparency, personalization, and access to information.India records 38% decline in TB mortality, treatment success rate rises to 94%: Centre 13/11/2026India's estimated TB mortality rate declined from 28 per lakh population in 2015 to 18 per lakh in 2025.IIT Kanpur study finds how pancreatic immune cells suppress insulin production 12/11/2026The study published in the Journal of Clinical Investigation, found that pancreatic immune cells called macrophages can directly communicate with insulin-producing beta cells and reduce insulin release. The researchers also confirmed that the same pathway is active in human pancreatic tissue, making it a potential target for future drug development.New blood test finds early risk for ovarian cancer 12/11/2026For decades, efforts to detect ovarian cancer earlier have focused on finding smaller tumors, the researchers noted in their report published on Tuesday in Nature Medicine. Pharma & Health NewsChemo drug supply crisis hits cancer care 05/06/2026Hospitals are reporting dwindling stocks, while patients and their families are being forced to hunt for pharmacies and distributors which have the drugs with them.Your weight-loss drugs set to become cheaper 28/02/2026India's anti-obesity market is set for a price revolution as multiple pharmaceutical companies prepare to launch affordable generic versions of blockbuster weight-loss drugs Wegovy and Ozempic following patent expiry. With over six players entering the market on day one, prices are expected to drop significantly, potentially halving the monthly cost for patients and widening access […]UK drugs giant AstraZeneca announces $15 bn investment in China 29/01/2026China is AstraZeneca's second-largest market after the United States, where the company has recently invested heavily under pressure from President Donald Trump.Yellow Fertility partners CARE IVF to expand presence in east, northeast India 14/01/2026The initiative is aimed at improving access to affordable in-vitro fertilisation (IVF) and assisted reproductive technology (ART) services, particularly in areas where patients often need to travel long distances for treatment.Novo Nordisk's US public affairs head leaves company, memo shows 06/01/2026The departure, previously unreported, sees U.S. public affairs head Jennifer Duck leave the firm. It follows a major global restructuring under CEO Mike Doustdar that includes cutting 9,000 jobs across departments and regions. One source said the memo was sent to staff late last week.Health push makes nutraceuticals India’s fastest-growing consumer segment, says Earthful 24/12/2025The company that sells nutrition supplements, is starting a community initiative focused on menopause awareness, offering stipends to women over 40 to lead conversations at the local and digital level.Alzheimer's drug hunt learns from cancer fight's multi-target playbook 12/12/2025Blood and genetic tests to accurately identify biomarkers of the disease are becoming available, but most diagnoses require a spinal tap or expensive PET scan. Not all patients are likely to benefit equally from anti-amyloid treatments.What Holds the Future of Pharma in the Middle East? 01/12/2025At the Economic Times Healthcare Leaders Summit Middle East 2025, pharmaceutical experts examined the shifting dynamics of the region’s drug market, discussing emerging trends, regulatory developments, and challenges that will shape the sector’s next phase of growth.What’s powering Mounjaro’s rise to the top of Indian drug market 04/11/2025Top officials and industry insiders attribute this ascent to a flurry of reasons – from the US drug maker’s shrewd marketing strategy and smart brand positioning as a weight-loss drug first to superior patient experience with faster and higher weight-loss efficacy and precise timing.Lilly partners with Nvidia on AI supercomputer to speed up drug development 29/10/2025Using the supercomputer, scientists at Lilly will be able to train AI models on millions of experiments to test potential medicines, expanding the scope of drug discovery efforts, the company said.Trump administration plans new probe into global drug pricing 22/10/2025The imminent investigation would consider whether U.S. trading partners are underpaying for drugs, the report said, adding that the investigation would come under Section 301 of the Trade Act of 1974.HC bins Roche's injunction plea, allows generic version of only drug for SMA 11/10/2025Govt's one-time aid of Rs 50 lakh for patients of rare diseases was not enough to cover even a year's treatment using Roche's patented version of Risdiplam, but at Natco's price for the generic version of the drug, treatment cost could be covered for 10-16 years.CDSCO to inspect cough syrup manufacturing units 10/10/2025The WHO has, meanwhile, expressed concern regarding the regulatory gap in diethylene glycol and ethylene glycol screening for domestically marketed medicines in India.US FDA approves first treatment for rare, life-threatening disease in males 20/09/2025According to a study on the National Institutes of Health's website, as of 2020, an estimated 230 to 250 males were identified with Barth syndrome worldwide.4 dead in gas leak at pharma firm 23/08/2025Chief of Palghar district disaster management cell, Vivekanand Kadam, said that between 2.30 pm and 3 pm, gas leaked from the nitrogen reaction tank at the pharma company, seriously affecting six persons working thereUS FDA approves Gilead's twice-yearly injection for HIV prevention 19/06/2025Lenacapavir, part of a class of drugs known as capsid inhibitors, proved nearly 100% effective at preventing HIV in large trials last year, raising new hope of interrupting transmission of the virus that infects 1.3 million people a year.Weight-loss surgery more effective than drugs in real world study 18/06/2025Semaglutide is the main ingredient in Novo Nordisk's Wegovy and Ozempic, while tirzepatide is the main ingredient in Eli Lilly's Zepbound and Mounjaro.Trump administration proposes cutting FDA budget by 5.5% 25/05/2025The proposed budget requested $93.8 billion for the Department of Health and Human Services - a cut of $33.3 billion, or 26.2% - from this year's budget of $127 billion, but did not mention the FDA. Makary's comments on Thursday were the first official outlining of the agency's 2026 budget request.Vertex misses quarterly results on weaker-than-expected demand for cystic fibrosis drug 06/05/2025In the first quarter ended March 31, sales of the company's older CF treatment, Trikafta, rose 2% to $2.53 billion but missed analysts' average expectation of $2.58 billion, according to LSEG data.Pharma companies must file compliance strategy 13/02/2025Small and medium manufacturers with turnover of less than ₹250 crore may seek extension of the timeline by submitting a plan of upgradation within three months from now, the drug regulatory authority said in a notification issued on Tuesday. WHO newsNew WHO technical package to help countries improve health data for COVID-19 response and beyond 10/10/2026Today, as part of its commitment to strengthening health information systems and improving health[1], especially in the context of the COVID-19 pandemic, WHO announced a new approach to improving access to life-saving data: the SCORE for Health Data Technical Package. The COVID-19 pandemic has highlighted the urgent need for timely and reliable data to drive […]COVID-19 disrupting mental health services in most countries, WHO survey 06/10/2020The COVID-19 pandemic has disrupted or halted critical mental health services in 93% of countries worldwide while the demand for mental health is increasing, according to a new WHO survey. The survey of 130 countries provides the first global data showing the devastating impact of COVID-19 on access to mental health services and underscores the […]Global partnership to make available 120 million affordable, quality COVID-19 rapid tests for low- and middle-income countries 28/09/2020A full access package includes WHO policy guidance on the use of antigen-based rapid diagnostic tests, manufacturer volume guarantees for low and middle-income countries, catalytic funding to assist governments to deploy the tests and an initial US$50 million procurement fundSeveral rapid, point-of-care antigen tests are being assessed by WHO for Emergency Use Listing (EUL)Agreements between […]Managing the COVID-19 infodemic: Promoting healthy behaviours and mitigating the harm from misinformation and disinformation 23/09/2020The Coronavirus disease (COVID-19) is the first pandemic in history in which technology and social media are being used on a massive scale to keep people safe, informed, productive and connected. At the same time, the technology we rely on to keep connected and informed is enabling and amplifying an infodemic that continues to undermine […]WHO’s three messages for UNGA75 15/09/2020As the world comes together at an unprecedented virtual session of the 75th UN General Assembly (UNGA), WHO has three messages to share.COVID-19 could reverse decades of progress toward eliminating preventable child deaths, agencies warn 09/09/2020With the number of under-five deaths at an all-time recorded low of 5.2 million in 2019, disruptions in child and maternal health services due to the COVID-19 pandemic are putting millions of additional lives at stakeThe number of global under-five deaths dropped to its lowest point on record in 2019 – down to 5.2 million […]In WHO global pulse survey, 90% of countries report disruptions to essential health services since COVID-19 pandemic 31/08/2020WHO to roll out learning and monitoring tools to improve service provision during pandemicThe World Health Organization (WHO) today published a first indicative survey on the impact of COVID-19 on health systems based on 105 countries’ reports. Data collected from five regions over the period from March to June 2020 illustrate that almost every country […]172 countries and multiple candidate vaccines engaged in COVID-19 vaccine Global Access Facility 24/08/2020Nine CEPI-supported candidate vaccines are part of the COVAX initiative, with a further nine candidates under evaluation, and procurement conversations on-going with additional producers not currently receiving research and development (R&D) funding through COVAX – giving COVAX the largest and most diverse COVID-19 vaccine portfolio in the world80 potentially self-financing countries have submitted non-binding expressions […]Global polio eradication initiative applauds WHO African region for wild polio-free certification 24/08/2020Today, the Africa Regional Certification Commission certified the WHO African Region as wild polio-free after four years without a case. With this historic milestone, five of the six WHO regions – representing over 90% of the world’s population – are now free of the wild poliovirus, moving the world closer to achieving global polio eradication. […]World Humanitarian Day 2020: A tribute to aid workers on the front lines 19/08/2020Amid a global pandemic, unprecedented needs and growing insecurity, aid workers and health-care responders are staying and delivering to the world’s most vulnerable people.Last year was the most violent on record for humanitarians, with 483 attacked, 125 killed, 234 wounded and 124 kidnapped. The UN condemns all attacks on humanitarians.OCHA and partners present the inspiring […]